McKesson Corporation

662.28
-4.08 (-0.61%)
At close: Mar 21, 2025, 2:50 PM
-0.61%
Bid 659.88
Market Cap 83B
Revenue (ttm) 342.74B
Net Income (ttm) 2.81B
EPS (ttm) 21.77
PE Ratio (ttm) 30.42
Forward PE 16.43
Analyst Buy
Ask 666.58
Volume 410,743
Avg. Volume (20D) 832,797
Open 666.72
Previous Close 666.36
Day's Range 661.50 - 670.79
52-Week Range 464.42 - 670.79
Beta 0.51

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management,...

Sector Healthcare
IPO Date Nov 10, 1994
Employees 45,000
Stock Exchange NYSE
Ticker Symbol MCK
Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $652, which is a decrease of -1.55% from the latest price.

Stock Forecasts

Next Earnings Release

McKesson Corporation is scheduled to release its earnings on May 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-1.18%
McKesson shares are trading lower after the compan... Unlock content with Pro Subscription
1 month ago
+0.59%
McKesson shares are trading lower after the company reported Q3 financial results and missed its revenue estimate.